|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.04 USD | -0.84% |
|
+0.79% | -27.89% |
| 07-31 | Mizuho Trims Price Target on Tarsus Pharmaceuticals to $98 From $100, Keeps Outperform Rating | MT |
| 07-16 | RxSight Names Aziz Mottiwala as CEO | MT |
| Market Cap | 2.54B 2.2B 2.05B 1.88B 3.56B 242B 3.62B 24.15B 9.49B 121B 9.54B 9.33B 400B | P/E 2026 * |
-28.2x | P/E 2027 * | 35.6x |
|---|---|---|---|---|---|
| Enterprise Value | 2.54B 2.2B 2.05B 1.88B 3.56B 242B 3.62B 24.15B 9.49B 121B 9.54B 9.33B 400B | EV / Sales 2026 * |
3.56x | EV / Sales 2027 * | 2.82x |
| Free-Float |
96.94% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tarsus Pharmaceuticals, Inc.
| 1 day | -0.84% | ||
| 1 week | +0.79% | ||
| Current month | -6.20% | ||
| 1 month | -6.20% | ||
| 3 months | -7.18% | ||
| 6 months | -8.52% | ||
| Current year | -27.89% |
| 1 week | 57.09 |  | 61.36 |
| 1 month | 53.89 | | 72.5 |
| Current year | 53.89 | | 83.92 |
| 1 year | 38.51 | | 85.25 |
| 3 years | 12.57 | | 85.25 |
| 5 years | 10.8 | | 85.25 |
| 10 years | 10.8 | | 85.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CEO | Chief Executive Officer | 48 | 01/09/2018 |
Jeffrey Farrow
DFI | Director of Finance/CFO | 64 | 24/04/2023 |
| Chief Tech/Sci/R&D Officer | 47 | 04/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CHM | Chairman | 48 | 02/12/2022 |
| Director/Board Member | 71 | 01/12/2019 | |
Bill Link
BRD | Director/Board Member | 80 | 01/01/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/03/26 | Sell | Chief Financial Officer | 6,430 | 0.0151% | ||
| 17/03/26 | Sell | General Counsel | 12,440 | 0.0292% | ||
| 15/03/26 | Fiscal year | Chief Operating Officer | 52,574 | 0.1235% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.84% | +0.79% | +47.60% | +157.70% | 2.56B | |
| +3.29% | +16.98% | +37.51% | +2.22% | 75.12B | |
| -2.75% | +48.50% | +48.50% | +48.50% | 49.48B | |
| +2.72% | -8.27% | +20.23% | +179.60% | 47.63B | |
| -3.81% | +6.32% | -54.61% | -53.87% | 42.95B | |
| -2.40% | +1.16% | +60.26% | -23.48% | 30.72B | |
| -2.82% | +2.43% | +54.12% | +89.44% | 24.93B | |
| -5.35% | -3.86% | +70.51% | -53.80% | 22.98B | |
| -1.59% | -4.78% | -11.93% | +136.89% | 19.56B | |
| -0.42% | +2.66% | +68.31% | +128.45% | 17.19B | |
| Average | -1.40% | +2.51% | +34.05% | +61.16% | 33.31B | |
| Weighted average by Cap. | -0.69% | +3.31% | +29.18% | +43.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 713M 618M 575M 529M 999M 67.97B 1.02B 6.78B 2.66B 33.86B 2.68B 2.62B 112B | 900M 781M 727M 668M 1.26B 85.87B 1.28B 8.56B 3.36B 42.77B 3.38B 3.31B 142B |
| Net income | -92.71M -80.42M -74.85M -68.77M -130M -8.84B -132M -882M -346M -4.4B -348M -341M -14.59B | 82.72M 71.76M 66.79M 61.37M 116M 7.89B 118M 787M 309M 3.93B 311M 304M 13.02B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | $59.04 | -0.84% | 637,019 |
| 30/07/26 | $59.54 | +1.74% | 699,198 |
| 29/07/26 | $58.52 | -0.73% | 679,842 |
| 28/07/26 | $58.95 | -1.95% | 510,219 |
| 27/07/26 | $60.12 | +2.49% | 725,405 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TARS Stock
Select your edition
All financial news and data tailored to specific country editions
